SHEA Guidelines and Expert Guidance Documents

SHEA Expert Guidance Documents, Expert Consensus Statements, Guidelines, and White Papers are developed by panels of experts who review the available evidence, and apply their clinical experience and expertise to make practical recommendations. The process for development of the first three types of documents is described in the Handbook for SHEA-Sponsored Expert Guidance, Consensus, and Guideline Documents (pdf). The Handbook does not define the development process for white papers. The Handbook is reviewed and updated periodically by the SHEA Guidelines Committee, and updates are approved by the Board of Trustees.

  • Infection Prevention and Control in the Long-Term Care Facility
    Archived - Clinical Practice, Guidelines, Infection Prevention, Long-Term Care
    Author:
    APIC, SHEA
    Published:
    September 1, 2008
    Abstract:

    This SHEA/APIC guideline provides recommendations for prevention and control of infections in long-term care facilities, including UTIs, respiratory tract infections, skin and soft-tissue infections and infestations, gastrointestinal infections, infections caused by antibiotic-resistant organisms, and epidemic infections. It also reviews the structure and elements of infection control programs in the long-term care setting, regulatory considerations, education, and surveillance.

    Authors: Bratzler D, Dellinger EP, Olsen K, Perl T, Autwaerter P, Bolon M, Fish D, Napolitano L, Sawyer R, Slain D, Steinberg J, Weinstein R

  • Raising Standards While Watching the Bottom Line: Making a Business Case for Infection Control
    Current - Institutional Policy
    Author:
    SHEA
    Published:
    September 30, 2007
    Abstract:

    The SHEA Board of Directors appointed a task force to draft this evidence‐based guideline to assist hospital epidemiologists in justifying and expanding their programs. Part 1 describes the basic steps needed to complete a business‐case analysis for an individual institution. A case study based on a representative infection control intervention is provided. Part 2 reviews important basic economic concepts and describes approaches that can be used to assess the financial impact of infection prevention, surveillance, and control interventions, as well as the attributable costs of specific healthcare‐associated infections. Both parts of the guideline aim to provide the hospital epidemiologist, infection control professional, administrator, and researcher with the tools necessary to complete a thorough business‐case analysis and to undertake an outcome study of a nosocomial infection or an infection control intervention.

    Authors: Eli N. Perencevich, Patricia W. Stone, Sharon B. Wright, Yehuda Carmeli, David N. Fisman, and Sara E. Cosgrove

We use cookies to help improve your experience
Ok